Allergy Therapeutics PLC Stock
€0.035
Your prediction
Allergy Therapeutics PLC Stock
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
Cons
Performance of Allergy Therapeutics PLC vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Allergy Therapeutics PLC | -2.820% | 4.545% | 27.778% | -27.368% | 60.465% | -86.731% | - |
Alliance Pharma plc | -5.100% | -4.124% | -8.824% | -51.688% | -7.921% | -65.872% | - |
Beximco Pharmaceuticals Ltd. GDR | - | 0.000% | -3.111% | 3.810% | -0.909% | -51.823% | -22.143% |
Cellectar BioSciences Inc. | -0.660% | 7.692% | 6.944% | 106.711% | 35.088% | -71.481% | - |
News
Will AT&T Increase Its Dividend This Year?
Before the pandemic disrupted its operations, AT&T (NYSE: T) was a reliable dividend stock. Not only that, but it was also a dividend-growth stock. For decades, the company increased dividend
Why AST SpaceMobile Stock Is Up Again Today
A day after AST SpaceMobile (NASDAQ: ASTS) stock got a big boost from the company solidifying a key partnership, Wall Street is rallying to the cause. Shares of the space communications company got
Why AST SpaceMobile Stock Is Blasting Off Today
Space mobility specialist AST SpaceMobile (NASDAQ: ASTS) is formalizing ties with partner AT&T ahead of its commercial launch this summer. That news, along with AST's latest earnings report, has the